HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Eric P Winer Selected Research

Breast Neoplasms (Breast Cancer)

11/2015Role of vascular density and normalization in response to neoadjuvant bevacizumab and chemotherapy in breast cancer patients.
11/2015Local Therapy Decision-Making and Contralateral Prophylactic Mastectomy in Young Women with Early-Stage Breast Cancer.
11/2015Pneumocystis jiroveci pneumonia (PCP) in patients receiving neoadjuvant and adjuvant anthracycline-based chemotherapy for breast cancer: incidence and risk factors.
11/2015Tailoring adjuvant chemotherapy regimens for patients with triple negative breast cancer.
10/2015Phase II study of tivantinib (ARQ 197) in patients with metastatic triple-negative breast cancer.
8/2015Phase II Study of Lapatinib in Combination With Trastuzumab in Patients With Human Epidermal Growth Factor Receptor 2-Positive Metastatic Breast Cancer: Clinical Outcomes and Predictive Value of Early [18F]Fluorodeoxyglucose Positron Emission Tomography Imaging (TBCRC 003).
7/2015Randomized Phase III Trial of Paclitaxel Once Per Week Compared With Nanoparticle Albumin-Bound Nab-Paclitaxel Once Per Week or Ixabepilone With Bevacizumab As First-Line Chemotherapy for Locally Recurrent or Metastatic Breast Cancer: CALGB 40502/NCCTG N063H (Alliance).
7/2015Racial and Ethnic Differences in Breast Cancer Survival: Mediating Effect of Tumor Characteristics and Sociodemographic and Treatment Factors.
7/2015Molecular Phenotype of Breast Cancer According to Time Since Last Pregnancy in a Large Cohort of Young Women.
6/2015Variation in type of adjuvant chemotherapy received among patients with stage I breast cancer: A multi-institutional study.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password:


Eric P Winer Research Topics

Disease

141Breast Neoplasms (Breast Cancer)
11/2015 - 06/2002
83Neoplasms (Cancer)
12/2015 - 05/2002
12Neoplasm Metastasis (Metastasis)
08/2014 - 09/2004
11Leukemia
09/2014 - 04/2003
3Peripheral Nervous System Diseases (PNS Diseases)
07/2015 - 09/2012
3Neutropenia
01/2015 - 11/2005
3Disease Progression
06/2012 - 06/2003
3Osteoporosis
01/2012 - 01/2005
2Pneumonia (Pneumonitis)
11/2015 - 02/2006
2Nausea
11/2015 - 12/2004
2Amenorrhea
06/2015 - 01/2005
2Hypertension (High Blood Pressure)
01/2015 - 10/2014
2Hemorrhage
01/2015 - 02/2008
2Fatigue
12/2014 - 10/2014
2Carcinoma (Carcinomatosis)
07/2013 - 05/2009
2Central Nervous System Diseases (CNS Diseases)
12/2011 - 03/2007
2Pneumocystis Pneumonia (Pneumocystis carinii Pneumonia)
08/2008 - 11/2006
2Endometrial Neoplasms (Endometrial Cancer)
02/2008 - 09/2007
2Uterine Neoplasms (Uterine Cancer)
04/2003 - 08/2002
1Lobular Carcinoma
09/2015
1Ductal Carcinoma
09/2015
1Infertility (Sterility)
06/2015
1Heart Failure
01/2015
1Thrombocytopenia (Thrombopenia)
01/2015
1Genetic Predisposition to Disease (Genetic Predisposition)
01/2015
1Infection
01/2015
1Diarrhea
12/2014
1Exanthema (Rash)
12/2014
1Circulating Neoplastic Cells
11/2014
1Ovarian Neoplasms (Ovarian Cancer)
10/2014
1Prostatic Neoplasms (Prostate Cancer)
04/2013
1Pheochromocytoma
01/2013

Drug/Important Bio-Agent (IBA)

31trastuzumab (Herceptin)FDA Link
08/2015 - 06/2002
26Paclitaxel (Taxol)FDA LinkGeneric
07/2015 - 06/2002
25Epidermal Growth Factor Receptor (EGF Receptor)IBA
08/2015 - 01/2003
25HormonesIBA
01/2015 - 08/2002
22TamoxifenFDA LinkGeneric
09/2015 - 08/2002
20Doxorubicin (Adriamycin)FDA LinkGeneric
11/2015 - 01/2003
20Cyclophosphamide (Cytoxan)FDA LinkGeneric
11/2015 - 01/2003
18Estrogens (Estrogen)FDA Link
07/2015 - 01/2003
12Aromatase InhibitorsIBA
01/2012 - 08/2002
10lapatinib (GW572016)FDA Link
08/2015 - 12/2007
8Aromatase (CYP19)IBA
12/2014 - 08/2002
8capecitabine (Xeloda)FDA Link
09/2014 - 12/2004
7Progesterone Receptors (Progesterone Receptor)IBA
12/2014 - 06/2006
5exemestane (Aromasin)FDA Link
01/2015 - 09/2007
5Fluorouracil (Carac)FDA LinkGeneric
01/2010 - 04/2006
5anastrozole (Arimidex)FDA LinkGeneric
02/2009 - 08/2002
5vinorelbine (Navelbine)FDA LinkGeneric
12/2008 - 08/2003
4bevacizumabFDA Link
11/2015 - 12/2008
4Biological Markers (Surrogate Marker)IBA
10/2015 - 01/2006
4Phenobarbital (Luminal)FDA Link
07/2015 - 10/2011
4taxaneIBA
01/2014 - 09/2007
4AnthracyclinesIBA
07/2009 - 01/2003
3letrozole (Femara)FDA LinkGeneric
09/2015 - 01/2003
3PlatinumIBA
06/2015 - 10/2014
3Carboplatin (JM8)FDA LinkGeneric
01/2015 - 07/2012
2hydroquinone (Black and White)FDA Link
07/2015 - 06/2015
24-iodo-3-nitrobenzamideIBA
12/2014 - 08/2014
2gemcitabineFDA Link
12/2014 - 12/2004
2docetaxel (Taxotere)FDA Link
01/2014 - 10/2013
2Cytochrome P-450 CYP2D6 (CYP2D6)IBA
10/2013 - 05/2008
24-amino-4'-hydroxylaminodiphenylsulfone (HADS)IBA
04/2013 - 04/2012
2Methotrexate (Mexate)FDA LinkGeneric
11/2012 - 05/2009
2TaxoidsIBA
06/2008 - 12/2004
2glucuronyl glucosamine glycan sulfate (Vessel)IBA
12/2007 - 01/2006
2Biological Tumor Markers (Tumor Markers)IBA
08/2003 - 06/2003
1Prednisone (Sone)FDA LinkGeneric
11/2015
1ARQ 197IBA
10/2015
1Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link
08/2015
1ixabepilone (BMS 247550)FDA Link
07/2015
1130-nm albumin-bound paclitaxelIBA
07/2015
1APTIBA
06/2015
1Messenger RNA (mRNA)IBA
03/2015
1MK 2206IBA
03/2015
1fulvestrant (Faslodex)FDA Link
12/2014
1B 31IBA
11/2014
14- ((4- Fluoro- 2- methyl- 1H- indol- 5- yl)oxy)- 6- methoxy- 7- (3- (pyrrolidin- 1- yl)propoxy)quinazoline (AZD2171)IBA
10/2014
1irinotecan (Camptosar)FDA LinkGeneric
08/2014
1Reactive Oxygen Species (Oxygen Radicals)IBA
08/2014
1Type I DNA Topoisomerases (Topoisomerase I)IBA
08/2014
1pertuzumabIBA
10/2013
14-hydroxy-N-desmethyltamoxifenIBA
10/2013
1vasectrin II (VS II)IBA
01/2013
1Small Interfering RNA (siRNA)IBA
01/2013
1Epidermal Growth Factor (EGF)IBA
12/2012
1N- (4- bromo- 2- fluorophenyl)- 6- methoxy- 7- ((1- methylpiperidin- 4- yl)methoxy)quinazolin- 4- amine (ZD6474)IBA
11/2012
1Genetic Markers (Genetic Marker)IBA
09/2012
1Estrogen Receptor Modulators (Antiestrogen)IBA
08/2012
1Transcription Factors (Transcription Factor)IBA
08/2012

Therapy/Procedure

51Drug Therapy (Chemotherapy)
11/2015 - 06/2002
21Adjuvant Chemotherapy
11/2015 - 04/2003
11Mastectomy (Mammectomy)
12/2015 - 02/2009
10Segmental Mastectomy (Lumpectomy)
12/2015 - 11/2008
7Radiotherapy
01/2015 - 09/2004
3Combination Drug Therapy (Combination Chemotherapy)
03/2015 - 04/2003
3Aftercare (After-Treatment)
11/2013 - 10/2004
2Hormone Replacement Therapy (Therapy, Hormone Replacement)
01/2008 - 08/2002
1Individualized Medicine
10/2013
1Neoadjuvant Therapy
09/2013